2024年11月12日,医疗设备公司英特格拉生命科学(IART)盘中股价大涨5.49%,最高触及26.26美元。这一走势引起了市场广泛关注。
英特格拉生命科学是一家总部位于新泽西州的医疗器械公司,主要从事再生疗法、肢体骨科和神经外科产品的开发和生产。公司市值约20亿美元,最近一个财季实现营收3.81亿美元,毛利2.14亿美元。其中医疗器械板块收入占比最高。
从公开数据来看,英特格拉盘中涨势或与以下几方面因素有关:一是公司最新财报数据表现较为亮眼,收入和利润均有不俗表现;二是机构给予公司较多买入和持有评级,认为公司发展前景向好;三是同行业医疗器械股整体涨幅较大,市场情绪偏向乐观。但目前尚未见到公司发布的直接相关重大利好消息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.